Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2005
10/26/2005EP1588727A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588726A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
10/26/2005EP1588718A1 Gene therapy of hepatocyte growth factor to enhance muscular and cutaneous flap survival
10/26/2005EP1588712A1 Modulators of regulatory proteins
10/26/2005EP1587954A1 Solid surface for biomolecule delivery and high-throughput assay
10/26/2005EP1587944A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
10/26/2005EP1587934A2 Improved genetic elements providing high levels of expression
10/26/2005EP1587925A2 A process for delivering sirna to cardiac muscle tissue
10/26/2005EP1587923A2 Improved constructs for expressing lysosomal polypeptides
10/26/2005EP1587910A2 Facls as modifiers of the rb pathway and methods of use
10/26/2005EP1587908A2 Cellular delivery and activation polypeptide-nucleic acid complexes
10/26/2005EP1587834A2 Uses of mammalian cytokine; related reagents
10/26/2005EP1587832A1 Factor viii polypeptide
10/26/2005EP1587830A1 Peptide inhibitors of toxins derived from ll-37
10/26/2005EP1587827A1 Obesity-related genes
10/26/2005EP1587545A2 Persistent expression of candidate molecule in proliferating stem and progenitor cells for delivery of therapeutic products
10/26/2005EP1587544A1 p53 TREATMENT OF PAPILLOMARIVUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS
10/26/2005EP1587543A1 Calcium phosphate ceramics and particles for in vivo and in vitro transfection
10/26/2005EP1159455B1 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
10/26/2005EP1109559B1 Inhibition of pathogenic processes related to tissue trauma
10/26/2005EP0988370B1 Electrospraying apparatus and method for introducing material into cells
10/26/2005EP0687301B1 Prohormone convertase transformed cells and polypeptide synthesis
10/26/2005CN1688715A Marker genes for determining renal toxicity
10/26/2005CN1688701A Mechanisms of myoblast transfer in treating heart failure
10/26/2005CN1688607A Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use
10/26/2005CN1688603A Treatment and prophylaxis with 4-1BB-binding agents
10/26/2005CN1688364A Use of murine genomic regions identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer
10/26/2005CN1688323A Lentiviral vector-mediated gene transfer and uses thereof
10/26/2005CN1688197A Gene therapy for critical limb ischemia with wild type or mutant eNOS
10/26/2005CN1688196A Hematopoietic stem cells and methods of treatment neogenesis vascular ophthalmopathy
10/26/2005CN1686566A Application of CARK gene in preparation of medicine for treating cardiac muscle hypertrophy and medicine for inhibiting cardiac muscle hypertrophy
10/26/2005CN1686565A Hepatitis B nucleic acid vaccine, its preparation method and application
10/26/2005CN1686564A Cocaine-benzedrine regulating transcription peptide gene vaccine, its preparation and application
10/26/2005CN1686563A Attenuated typhoid bacillus vaccine of virus gene carried on chromosome and its preparation method
10/26/2005CN1224712C Vector
10/26/2005CN1224708C i (Neisseria meningitidis) antigens
10/26/2005CN1224699C Preparation method for tumour cell comprising interleukin-23 gene and its use
10/26/2005CN1224627C Modified factor VIII
10/25/2005US6958386 MUM-1 protein expressed by multiple myeloma-related gene
10/25/2005US6958320 Sel-12 related methods
10/25/2005US6958318 Recombinant bacterial cells for delivery of PNP to tumor cells
10/25/2005US6958238 Isolated dishevelled associated kinases, polynucleotides encoding the kinases, and methods of use thereof
10/25/2005US6958147 Use of VEGF-C to prevent restenosis
10/25/2005CA2429724C Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
10/25/2005CA2251232C Method for gene transfer to the central nervous system
10/21/2005CA2504582A1 Drug delivery device comprising a bilayered polymeric coating having an inhibitor of the mamalian target of rapamycin incorporated into the first polymeric coating layer
10/21/2005CA2504401A1 Drug delivery systems for the prevention of neointimal hyperlasia
10/20/2005WO2005097995A1 CANCER THERAPY VIA THE INHIBITION OF Skp-2 EXPRESSION
10/20/2005WO2005097993A2 Immunostimulatory viral rna oligonucleotides
10/20/2005WO2005097988A1 Bone marrow-relevant cell participating the maintenance and/or repair of tissue
10/20/2005WO2005097981A2 Novel herpes simplex viruses
10/20/2005WO2005097207A2 Rna interference modulators of hedgehog signaling and uses thereof
10/20/2005WO2005097206A2 Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
10/20/2005WO2005097205A2 Dna virus microrna and methods for inhibiting same
10/20/2005WO2005097204A1 Preventives/remedies for cancer
10/20/2005WO2005097171A1 Antiobesity drug
10/20/2005WO2005097155A1 Neurite elongation inducing agent
10/20/2005WO2005096781A2 Methods and compositions for treating gain-of-function disorders using rna interference
10/20/2005WO2005096693A2 Cancer prognosis and/or diagnosis method
10/20/2005WO2005084713A3 Enzyme-prodrug therapy for prosthetic joint repair
10/20/2005WO2005049844A3 Vectors, mutant viruses and methods for generating mutant viruses
10/20/2005WO2005049800A3 Methods for screening for agents capable of modulating t lymphocyte function in response to a herpes simplex virus-infected cell
10/20/2005WO2005045428A3 Methods and compositions for modulating apoptosis
10/20/2005WO2005005603A3 Method for inducing an immune response to cancer antigen
10/20/2005WO2004112575A3 Gene amplification and overexpression in cancer
10/20/2005WO2004064785A3 Cancer therapy sensitizer
10/20/2005US20050235371 Noval modified MSP-1 nucleic acid sequences and methods for increasing mRNA levels and protein expression in cell systems
10/20/2005US20050235367 Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
10/20/2005US20050234226 Persephin and related growth factors
10/20/2005US20050234008 Diagnosis of a person's risk of developing atherosclerosis or diabetic retinopathy based on leucine 7 to proline 7 polymorphism in the prepro-neuropeptide Y gene
10/20/2005US20050234007 RNA interference mediating small RNA molecules
10/20/2005US20050234006 RNA interference mediating small RNA molecules
10/20/2005US20050234005 Cloning and expression of the full length 110 KDa antigen of Orientia tsutsugamushi to be used as a vaccine component against scrub typhus
10/20/2005US20050234004 Compositions and methods of use of W-peptides
10/20/2005US20050234003 Method of using nucleic acid compositions for muting expression of a gene in animals
10/20/2005US20050234002 Antisense oligomers and methods for inducing immune tolerance and immunosuppression
10/20/2005US20050234000 SiRNA delivery into mammalian nerve cells
10/20/2005US20050233999 That contain unmethylated cytosine-guanine (CpG) dinucleotides; stimulate an immune response and to redirect a Th2 response to a Th1 response; use with vaccines
10/20/2005US20050233998 useful in modulating vascular endothelial growth factor (VEGF) and/or vascular endothelial growth factor receptor (e.g., VEGFR) gene expression; use in therapeutic, diagnostic, target validation, and genomic discovery
10/20/2005US20050233996 RNA interference mediated inhibition of hairless (HR) gene expression using short interfering nucleic acid (siNA)
10/20/2005US20050233995 Immunostimulatory nucleic acid molecules
10/20/2005US20050233994 Methods and vectors for expressing siRNA
10/20/2005US20050233993 Methods for promoting homologous recombination
10/20/2005US20050233992 Regeneration of endogeneous myocardial tissue by induction of neovascularization
10/20/2005US20050233991 Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
10/20/2005US20050233990 Anti-cancer agents comprising disintegrin genes and the treating methods
10/20/2005US20050233985 Rsk inhibitors and therapeutic uses thereof
10/20/2005US20050233962 Administering vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), basic fibroblast growth factor or functional fragment or nucleic acid encoding these
10/20/2005US20050233959 Use of MDA-7 to inhibit pathogenic infectious organisms
10/20/2005US20050233957 Sodium channel regulators and modulators
10/20/2005US20050233956 Proteins involved in the regulation of energy homeostasis
10/20/2005US20050233955 Stimulation of nerve cell regeneration
10/20/2005US20050233457 Recombining viral vectors for the tetracycline-regulated expression of genes
10/20/2005US20050233455 Acyclic linker-containing oligonucleotides and uses thereof
10/20/2005US20050233417 Growth hormone variations in humans and their uses
10/20/2005US20050233413 Neuroprotective polypeptides and methods of use
10/20/2005US20050233402 Heparinase III HLGAG fragments and uses thereof
10/20/2005US20050233385 Using antibodies on cell surfaces
10/20/2005US20050233359 Isolated nucleic acid molecule encoding a neurotrophic growth factor
10/20/2005US20050233347 Can be used for the treatment of diabetes or for delaying the onset of diabetes
1 ... 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 ... 870